5-Nitro-1,10-phenanthroline demonstrates an ability to associate with ferriprotoporphyrin IX, with a Log K value of 2.88. It exhibits mutagenic activity in an Ames test on Salmonella Typhimurium TA98, with an activity level of 0.59 log of revertants/nmol, and has a partition coefficient (logP) value of 1.84. Bioactivity assays show that 5-Nitro-1,10-phenanthroline potently inhibits Tau fibril formation, ALDH1A1, Mycobacterium tuberculosis H37Rv, Fructose-1,6-bisphosphate Aldolase, L3MBTL1, JMJD2A-Tudor Domain, BAZ2B, ELG1-dependent DNA repair, the malarial parasite plastid, Giardia lamblia, TGF-b, Vif-A3F interactions, GLP-1 receptor inverse agonists, Hepatitis C Virus (HCV), induces DNA re-replication, ATXN expression, human tyrosyl-DNA phosphodiesterase 1 (TDP1), and shows synthetic lethality in tumor cells producing 2HG, with potencies primarily in the nanomolar range. Additionally, 5-Nitro-1,10-phenanthroline exhibits antibacterial activity against Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Staphylococcus aureus MRSA, and Acinetobacter baumannii, with inhibition ranging from 9.1% to 15.65%, and antifungal activity against Candida albicans, albeit lower at 0.77%. It demonstrates no efficacy against Cryptococcus neoformans. Against Mycobacterium tuberculosis H37Rv, it has a MIC99 of 0.78 µM, and it exhibits cytotoxicity against human THP-1 cells with a CC50 greater than 25,000 nM after 96 hours of treatment..
Note: Summary generated by AI. Data source: ChEMBL 